Muraglitazar (proposed tradename Pargluva) is a dual peroxisome proliferator-activated receptor agonist with affinity to PPARα and PPARγ.
{{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 407806745 | IUPAC_name = N-[(4-Methoxyphenoxy)carbonyl]-N-{4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]benzyl}glycine | image = Muraglitazar.svg | image_class = skin-invert-image | width = 315
| tradename = | pregnancy_AU = | pregnancy_US = | pregnancy_category = | legal_AU = | legal_CA = | legal_UK = | legal_US = | legal_status = Development terminated | routes_of_administration =
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).